key: cord-0882922-gtc3pqix
authors: McCarthy, Elissa; DeViva, Jason C.; Na, Peter J.; Pietrzak, Robert H.
title: New‐onset and exacerbated insomnia symptoms during the COVID‐19 pandemic in US military veterans: A nationally representative, prospective cohort study
date: 2021-07-30
journal: J Sleep Res
DOI: 10.1111/jsr.13450
sha: f02bd58442d38d94a497cbc0b13b6cac03f4a2c9
doc_id: 882922
cord_uid: gtc3pqix

The COVID‐19 pandemic has had a negative impact on physical and mental health worldwide. While pandemic‐related stress has also been linked to increased insomnia, scarce research has examined this association in nationally representative samples of high‐risk populations, such as military veterans. We evaluated pre‐ and pandemic‐related factors associated with new‐onset and exacerbated insomnia symptoms in a nationally representative sample of 3,078 US military veterans who participated in the National Health and Resilience in Veterans Study. Veterans were surveyed in the USA in 11/2019 (pre‐pandemic) and again in 11/2020 (peri‐pandemic). The Insomnia Severity Index was used to assess severity of insomnia symptoms at the pre‐ and peri‐pandemic assessments. Among veterans without clinical or subthreshold insomnia symptoms pre‐pandemic (n = 2,548), 11.5% developed subthreshold (10.9%) or clinical insomnia symptoms (0.6%) during the pandemic; among those with subthreshold insomnia symptoms pre‐pandemic (n = 1,058; 26.0%), 8.0% developed clinical insomnia symptoms. Pre‐pandemic social support (21.9% relative variance explained), pandemic‐related stress related to changes in family relationships (20.5% relative variance explained), pre‐pandemic chest pain (18.5% relative variance explained) and weakness (11.1% relative variance explained), and posttraumatic stress disorder (8.2% relative variance explained) explained the majority of the variance in new‐onset subthreshold or clinical insomnia symptoms during the pandemic. Among veterans with pre‐pandemic subthreshold insomnia, pandemic‐related home isolation restrictions (59.1% relative variance explained) and financial difficulties (25.1% relative variance explained) explained the majority of variance in incident clinical insomnia symptoms. Taken together, the results of this study suggest that nearly one in five US veterans developed new‐onset or exacerbated insomnia symptoms during the pandemic, and identify potential targets for prevention and treatment efforts.

The COVID-19 pandemic has had a negative impact on physical and mental health worldwide. While pandemic-related stress has also been linked to increased insomnia, scarce research has examined this association in nationally representative samples of high-risk populations, such as military veterans. We evaluated pre-and pandemicrelated factors associated with new-onset and exacerbated insomnia symptoms in a nationally representative sample of 3,078 US military veterans who participated in the National Health and Resilience in Veterans Study. Veterans were surveyed in the USA in 11/2019 (pre-pandemic) and again in 11/2020 (peri-pandemic). The Insomnia Severity Index was used to assess severity of insomnia symptoms at the pre-and peri-pandemic assessments. Among veterans without clinical or subthreshold insomnia symptoms pre-pandemic (n = 2,548), 11.5% developed subthreshold (10.9%) or clinical insomnia symptoms (0.6%) during the pandemic; among those with subthreshold insomnia symptoms pre-pandemic (n = 1,058; 26.0%), 8.0% developed clinical insomnia symptoms. Pre-pandemic social support (21.9% relative variance explained), pandemic-related stress related to changes in family relationships (20.5% relative variance explained), pre-pandemic chest pain (18.5% relative variance explained) and weakness (11.1% relative variance explained), and posttraumatic stress disorder (8.2% relative variance explained) explained the majority of the variance in new-onset subthreshold or clinical insomnia symptoms during the pandemic. Among veterans with pre-pandemic subthreshold insomnia, pandemic-related home isolation restrictions (59.1% relative variance explained) and financial difficulties (25.1% relative variance explained) explained the majority of variance in incident clinical insomnia symptoms.

Taken together, the results of this study suggest that nearly one in five US veterans developed new-onset or exacerbated insomnia symptoms during the pandemic, and identify potential targets for prevention and treatment efforts.

COVID-19, insomnia symptoms, mental health, pandemic, veteran

One of the most common models of the development of insomnia (Spielman, Caruso, & Glovinsky, 1987) posits that precipitating factors, which include psychosocial stressors, changes in health or changes in routine, interact with predisposing factors (e.g. gender, arousal tendency) to insomnia to create short-term sleep problems that may persist over time. The COVID-19 pandemic could serve as a precipitant for insomnia symptoms in multiple ways (e.g. increased distress, changes in health or daily routine), and research has indicated that the pandemic period has been associated with increased incidence of insomnia (Killgore et al., 2020; Wu et al., 2021; Yuksel et al., 2021) . Poorer pandemic sleep has been associated with female gender, employment, family responsibilities, chronic illness, consuming > 6 alcoholic beverages per week, higher stress levels, younger age, adverse changes in livelihood, and higher levels of stress (Killgore et al., 2020; Mandelkorn et al., 2021; Yuksel et al., 2021) .

A recent meta-analysis found a higher prevalence of mental health problems during the pandemic, including insomnia (Wu et al., 2021) . Individuals with insomnia symptoms before or after the pandemic may have increased stress, anxiety and depressive symptoms during the pandemic than those with no insomnia symptoms (Meaklim, Junge, Varma, Finck, & Jackson, 2021) . A survey of the US adult population (N = 1,013) during the pandemic revealed elevated rates of insomnia (subthreshold 30.6%; moderate range 19.8%; severe range 5.2%; Killgore et al., 2020) . Further, a national survey (N = 1,116) in China found that the COVID-19 pandemic was associated with increased prevalence of subthreshold and threshold insomnia symptoms relative to pre-pandemic rates (31.5% versus 24.8%, respectively; Sun, Qin, Basta, Chen, & Li, 2021) . A second population-based survey in China (N = 56,679) found that 23.5% (N = 13,308) of participants had subthreshold insomnia symptoms, and 5.7% (N = 3,256) had moderate/severe insomnia symptoms during the pandemic (Shi et al., 2020) .

Military veterans are more likely than the general adult population to develop insomnia (Byrne, McCarthy, DeViva, Southwick, & Pietrzak, 2021) . Given this increased predisposition, veterans may therefore be more likely to develop insomnia in response to a highly stressful precipitating event such as the COVID-19 pandemic. As insomnia symptoms are associated with an array of negative outcomes among veterans (Byrne et al., 2021; Department of Veterans Affairs & Department of Defense, 2019), determining whether the COVID-19 pandemic is associated with changes in the incidence of clinically significant insomnia symptoms has important implications for clinical practice and intervention strategies specific to this population.

Using data from a contemporary, nationally representative sample of US veterans, the purpose of the current study was twofold:

(1) identify changes in the prevalence of clinical and subthreshold insomnia symptoms during the pandemic; and (2) evaluate pre-and peri-pandemic factors associated with new-onset and exacerbated insomnia symptoms in this population. Given the broad range of factors linked to insomnia (Killgore et al., 2020; Mandelkorn et al., 2021; Yuksel et al., 2021) , we explored how a comprehensive array of preand peri-pandemic risk and protective factors related to new-onset and exacerbated insomnia symptoms. In addition, given the high prevalence of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) in veterans (Armenta et al., 2019) , as well as a strong association between these disorders and insomnia (Britton, McKinney, Bishop, Pigeon, & Hirsch, 2019) , we additionally considered how these pre-existing psychiatric morbidities might influence pandemic-related changes in insomnia symptoms.

Data were analysed from the 2019-2020 National Health and 

The Insomnia Severity Index (ISI; Morin, Belleville, Bélanger, & Ivers, 2011) was used to assess the severity of insomnia symptoms. The ISI is a 7-item self-report questionnaire that assesses the nature, severity and impact of insomnia over the past 2 weeks (Cronbach's α = 0.89 and 0.88 at pre-and peri-pandemic assessments, respectively). Total scores on the ISI range from 0 to 28, with scores of 0-7 indicative of no clinically significant insomnia symptoms; 8-14 subthreshold insomnia symptoms; 15-21 clinical insomnia (moderate severity) symptoms; and 22-28 clinical insomnia (severe) symptoms. At both assessments in the current study, veterans were classified on the basis of total ISI scores into the following groups: no insomnia symptoms (score of 0-7); subthreshold insomnia symptoms (score of 8-14); and clinical insomnia symptoms (score of 15-28). For the purposes of this study, scores of 15 or higher were collapsed into a single clinical insomnia category, as this score threshold has been recommended for epidemiological studies (Morin et al., 2011) . Table 1 describes pre-pandemic and peri-pandemic factors that were examined in relation to new-onset and exacerbated insomnia.

Data analyses proceeded in five steps. First, we computed descriptive statistics to identify the incidence of new-onset and exacerbated insomnia symptoms over the 1-year study period. Second, we conducted chi-squares and independent-samples t-tests to compare pre-and peri-pandemic factors in: (1) veterans with new-onset insomnia symptoms versus veterans without insomnia symptoms at both assessments; and (2) veterans with subthreshold insomnia symptoms at the pre-pandemic assessment who did and did not develop clinical insomnia symptoms at the peri-pandemic assessment.

These analyses were used to help guide variable selection for the multivariable models. Third, we conducted two multivariable binary logistic regression analyses to identify pre-pandemic risk factors and peri-pandemic correlates associated with new-onset and exacerbated insomnia. Variables that differed by group at the p < 0.05 level in bivariate analyses were entered into these analyses. Fourth, planned post hoc analyses of composite variables (e.g. protective psychosocial characteristics) were conducted to identify specific aspects of these variables that were associated with new-onset and exacerbated insomnia symptoms; α was set to 0.01 in these analyses to reduce the likelihood of Type I error. Fifth, relative importance analyses were conducted to identify relative variance in new-onset and exacerbated insomnia symptoms explained by each significant variable identified in multivariable analyses.

Among veterans without insomnia symptoms pre-pandemic (n = 2,548), 11.5% developed subthreshold (10.9%) or clinical (0.6%) insomnia symptoms during the pandemic (these groups were combined for subsequent analyses due to the low incidence of clinical insomnia symptoms). Among veterans with subthreshold insomnia symptoms pre-pandemic (n = 1,058; 26.0%), 8.0% developed clinical insomnia symptoms during the pandemic. Table 2 shows results of bivariate and multivariable analyses of pre-and peri-pandemic factors associated with new-onset insomnia symptoms. Results of a multivariable analysis revealed that greater adverse childhood experiences (ACEs), and pre-pandemic PTSD, so- Relative importance analyses indicated that pre-pandemic social support (21.9%), pandemic-related stress related to changes in family relationships (20.5%), pre-pandemic chest pain (18.5%), weakness (11.1%) and PTSD (8.2%) explained the majority of the variance in incident subthreshold or clinical insomnia symptoms, with pre-pandemic ADL/IADL disability (7.5%), childhood physical abuse (5.6%), pandemic-related changes in relationships with others (4.6%) and COVID-19 infection (2.1%) accounting for the remaining variance in this outcome. Table 3 shows results of bivariate and multivariable analyses of pre-pandemic risk factors and peri-pandemic correlates of exacerbated insomnia symptoms in veterans with subthreshold insomnia symptoms at the pre-pandemic assessment. Results of a multivariable analysis revealed that greater ACEs and pandemic-related social restriction and financial stress were independently associated with incident clinical insomnia symptoms.

Planned post hoc analyses revealed that having a household member with mental illness or who attempted suicide during childhood (OR = 2.69, 1.40-5.16); pandemic-related stress related to home isolation restrictions (OR = 1.49, 95% CI = 1.09-2.04); and pandemic-related financial difficulties (OR = 1.51, 95% CI = 1.14-1.98) were associated with incident clinical insomnia symptoms.

Relative importance analyses indicated that pandemic-related home isolation restrictions explained the majority of variance in TA B L E 1 Measures of psychiatric, sociodemographic, military and psychosocial variables, and COVID-19 infection and pandemic stressors Total traumas Total count of potentially traumatic events endorsed on Life Events Checklist for DSM-5 (LEC-5; Weathers, Blake, et al., 2013) Lifetime MDD Lifetime MDD was assessed according to DSM-5 diagnostic criteria using a modified self-report version of the MINI (Sheehan, 2016) Lifetime PTSD Lifetime PTSD was defined as a score of 33+ (Bovin et al., 2016) on the PCL-5 (Weathers, Litz, et al., 2013) , which was modified to include lifetime ratings of all PTSD symptoms in relation to veterans' selfreported "worst" Criterion A trauma on the LEC-5 (Weathers, Blake, et al., 2013) Lifetime AUD Lifetime AUD was defined as meeting DSM-5 diagnostic criteria for AUD using a modified self-report version of the MINI (Sheehan, 2016) Lifetime DUD Lifetime DUD was defined as meeting DSM-5 diagnostic criteria for AUD using a modified self-report version of the MINI (Sheehan, 2016) Loneliness Score on 3-item measure adapted from the UCLA Loneliness Scale (Hughes, Waite, Hawkley, & Cacioppo, 2004) Number of medical conditions Sum of number of medical conditions endorsed in response to question: "Has a doctor or healthcare professional ever told you that you have any of the following medical conditions?" (e.g. arthritis, cancer, diabetes, heart disease, asthma, kidney disease); range: 0-24 conditions Somatic symptoms Score on Somatization Subscale of the Brief Symptom Inventory-18 (Derogatis, 2000) Disability in any ADL/IADL Any disability in ADL. The following question was asked: "At the present time, do you need help from another person to do the following?" (e.g. bathe; walk around your home or apartment; get in and out of the chair) Endorsement of any of these activities was indicative of having a disability with an ADL (Hardy & Gill, 2004) Pre-pandemic psychosocial protective factors

Factor score using the following six indicators: score on Purpose in Life Test-Short Form (Schulenberg, Schnetzer, & Buchanan, 2011) ; score on Connor-Davidson Resilience Scale-10 (Campbell-Sills & Stein, 2007); rating (1 = strongly disagree to 7 = strongly agree) on single-item measure of optimism from Life Orientation Test-Revised ("In uncertain times, I usually expect the best"; Scheier, Carver, & Bridges, 1994); rating (1 = strongly disagree to 7 = strongly agree) on single-item measure of gratitude from Gratitude Questionnaire ("I have so much in life to be thankful for"; McCullough, Emmons, & Tsang, 2002); rating (1 = strongly disagree to 7 = strongly agree) on single-item measure of curiosity/exploration from Curiosity and Exploration Inventory-II ("I frequently find myself looking for new opportunities to grow as a person"; Kashdan et al., 2009) ; rating (1 = strongly disagree to 7 = strongly agree) on single item measuring perceived level of community integration ("I feel well integrated in my community")

Factor score using the following three measures as indicators: score on 5-item Medical Outcomes Study Social Support Scale (Sherbourne & Stewart, 1991) ; size of social network as assessed by the question, "About how many close friends and relatives do you have (people you feel at ease with and can talk to about what is on your mind)?"; secure attachment style as measured by the Attachment Style Questionnaire (ASQ; Hazan & Shaver, 1987) COVID-19 infection stressors COVID-19 infection status (endorsement of: self-infected, know someone in household who was infected, know someone not in household who was infected, and know someone who died of COVID-19) was assessed using the Assessment of Exposure to COVID-19 scale developed by the National Center for PTSD COVID-19 pandemic stressors Questions from the Coronavirus Health Impact Survey (National Institute of Mental Health, 2020) were used to assess COVID-19-associated media consumption, and worries and concerns at the peripandemic assessment Factor analysis revealed that these items loaded on five factors (eigenvalues = 1.01-4.94): COVID-19related disease worries (e.g. "In the past month, how worried have you been about being infected with coronavirus?"); COVID-19 social restriction stress (e.g. "How stressful have these changes in social contacts been for you?"); COVID-19-associated socioeconomic stress (e.g. "In the past month, to what degree have changes associated to the pandemic created financial problems for you or your family?"); COVID-19-associated relationship difficulties (e.g. "Has the quality of the relationships between you and members of your family changed?"); and COVID-19-associated social engagement (e.g. "In the past month, how many people, from outside of your household ACEs, adverse childhood experiences; ADL, activity of daily living; AUD, alcohol use disorder; CI, confidence interval; DUD, drug use disorder; IADL, instrumental activity of daily living; MDD, major depressive disorder; OR, odds ratio; PTSD, posttraumatic stress disorder.

TA B L E 3 Sociodemographic, pre-pandemic risk factors and peri-pandemic correlates of incident clinical insomnia symptoms among US military veterans with pre-pandemic subthreshold insomnia symptoms (Mandelkorn et al., 2021; Robillard et al., 2021; Yuksel et al., 2021) . Specifically, our results revealed that lower pre-pandemic social connectedness and greater pandemic-related stress due to changes in family relationships were most strongly associated with the development of subthreshold or clinical insomnia symptoms during the pandemic. Somatic symptoms such as chest pain and weakness and pre-existing PTSD also emerged as significant predictors of new-onset insomnia symptoms.

These findings are consistent with prior work suggesting a link between somatic symptoms, trauma and insomnia symptoms (Astill Wright et al., 2021) , and suggest that veterans with pre-existing physical and mental health difficulties may be at increased risk for developing sleep difficulties during the pandemic.

Pandemic-related home isolation restrictions were most strongly associated with the development of clinical insomnia symptoms among veterans with subthreshold insomnia symptoms at the prepandemic assessment. Home isolation can limit activities, disrupt healthy schedules and increase unhealthy compensatory behaviours (e.g. sedentary activities, alcohol consumption), thus increasing risk for the development of insomnia symptoms (Mandelkorn et al., 2021; Robillard et al., 2021) . Pandemic-related financial stress and having a family member with history of mental illness who may be more vulnerable to the negative impact of the pandemic (Yao, Chen, & Xu, 2020) could both function as additional sources of stress, which could in turn disrupt sleep (Mandelkorn et al., 2021; Robillard et al., 2021 , Yuksel et al., 2021 .

The current study has some noteworthy limitations. The NHRVS is a large epidemiological study and relied on self-report Significant association: * p < 0.05; ** p < 0.01; *** p < 0.001.

ACEs, adverse childhood experiences; ADL, activity of daily living; AUD, alcohol use disorder; CI, confidence interval; DUD, drug use disorder; IADL, instrumental activity of daily living; MDD, major depressive disorder; OR, odds ratio; PTSD, posttraumatic stress disorder.

questionnaires as opposed to structured clinical interviews. We also administered the ISI, which is not a diagnostic tool, to identify levels of insomnia symptoms. The use of a subjective sleep selfreport instrument of insomnia symptoms also does not provide in- is possible that the observed incidence of insomnia symptoms simply reflect normative fluctuations or incidence rates) or whether the results are specific to veterans. Further research using structured interviews and diagnostic assessments of insomnia-related disorders is needed to extend these results in veterans and other at-risk populations.

The current study provides the first known population-based data on pre-to-peri-pandemic changes in insomnia symptoms in US military veterans. Results suggest that prevention and treatment efforts that target specific risk factors/subpopulations (e.g. low social connectedness, pre-existing physical and mental health issues), and that address pandemic-related social and financial stressors may help mitigate risk for the development or exacerbation of insomnia symptoms. Consistent with one of the most well-known models of insomnia development (Spielman et al., 1987) , veterans have increased predisposing factors for insomnia, as well as a potential precipitating factor-pandemicrelated stressors-that may collectively increase risk for the develop- mitigating insomnia symptoms in veterans and other populations whose sleep has been adversely impacted by the pandemic. Pietrzak: writing -review and editing.

Data available on request from the authors.

https://orcid.org/0000-0003-3022-0509

Longitudinal trajectories of comorbid PTSD and depression symptoms among U.S. service members and veterans

Disturbed sleep connects symptoms of posttraumatic stress disorder and somatization: A Network Analysis Approach

Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans

Insomnia and risk for suicidal behavior: A test of a mechanistic transdiagnostic model in veterans

Prevalence, risk correlates, and health comorbidities of insomnia in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study

Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience

Current Population Survey

Clinical Practice Guideline for the Management of Chronic Insomnia and Obstructive Sleep Apnea

BSI-18: Brief Symptom Inventory 18 -Administration, scoring, and procedures manual

Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline

A revised inventory of Adverse Childhood Experiences

Path to Better Sleep Course

Recovery from disability among community-dwelling older persons

Romantic Love Conceptualized as an Attachment Process

Comparative associations of problematic alcohol and cannabis use with suicidal behavior in U.S. military veterans: A population-based study

A short scale for measuring loneliness in large surveys: Results from two population-based studies

The Curiosity and Exploration Inventory-II: Development, factor structure, and psychometrics

Suicidal ideation during the COVID-19 pandemic: The role of insomnia

Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study

The grateful disposition: A conceptual and empirical topography

Pre-existing and post-pandemic insomnia symptoms are associated with high levels of stress, anxiety and depression globally during the COVID-19 pandemic

The Insomnia Severity Index: Psychometric indicators to detect insomnia cases and evaluate treatment response

from National Institute of Mental Health Intramural Research Program Mood Spectrum Collaboration

Profiles of sleep changes during the COVID-19 pandemic: Demographic, behavioural and psychological factors

Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and selfesteem): A reevaluation of the Life Orientation Test

The purpose in life test-short form: Development and psychometric support

Mini International Neuropsychiatric Interview

The MOS social support survey

Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic

A behavioral perspective on insomnia treatment

Psychological reactions and insomnia in adults with mental health disorders during the COVID-19 outbreak

The Life Events Checklist for DSM-5 (LEC-5). Instrument Available from the National Center for PTSD at www

The PTSD Checklist for DSM-5 (PCL-5). Scale Available from the National Center for PTSD at

Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis

Patients with mental health disorders in the COVID-19 epidemic. The Lancet

Sleeping when the world locks down: Correlates of sleep health during the COVID-19 pandemic across 59 countries

New-onset and exacerbated insomnia symptoms during the COVID-19 pandemic in US military veterans: A nationally representative, prospective cohort study